VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions

被引：1
|
作者：
Yang, Yaning
Liu, Chengming
Yang, Guangjian
Xu, Haiyan
Lei, Siyu
Wang, Yan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
VEGFA; targeted therapy; resistance; EGFR exon 20 insertions; non-small cell lung cancer;
D O I：
10.1158/1538-7445.AM2024-3263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3263
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Acquired resistance of non-small cell lung cancer to EGFR-TKI: Role of AKT3.
    Huang, Shih-Hsiang
    Shih, Jin-Yuan
    Chen, Ching-Chow
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 55 - 56
  • [32] The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancer
    Xu Yufen
    Song Binbin
    Chen Wenyu
    Liu Jialiang
    Yang Xinmei
    SPRINGERPLUS, 2016, 5
  • [33] Synergistic effect of metformin and EGFR-TKI in the treatment of non-small cell lung cancer
    Wang, Haocheng
    Yang, Xue
    Sun, Yang
    Li, Yanan
    Dong, Ya
    Shan, Dongfeng
    Yu, Zhuang
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (01) : 372 - 381
  • [34] Possible differential EGFR-TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancer
    Kaneda, Toshihiko
    Hata, Akito
    Tomioka, Hiromi
    Tanaka, Kosuke
    Kaji, Reiko
    Fujita, Shiro
    Tomii, Keisuke
    Katakami, Nobuyuki
    LUNG CANCER, 2014, 86 (02) : 213 - 218
  • [35] Analysis of the EGFR mutations in non-small cell lung cancer patients after EGFR-TKI treatment.
    Yamaguchi, H.
    Ikeda, T.
    Tomonaga, N.
    Nakano, H.
    Kitazaki, T.
    Doi, S.
    Nakatomi, K.
    Iida, T.
    Nakamura, Y.
    Kohno, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] The state of the art of EGFR exon 20 insertions in non-small cell lung cancer: Diagnosis and future perspectives
    Dorta-Suarez, Miriam
    de Miguel, Maria
    Amor-Carron, Oscar
    Calderon, Jose Miguel
    Gonzalez-Ortega, Mcarmen
    Rodriguez-Abreu, Delvys
    CANCER TREATMENT REVIEWS, 2024, 124
  • [37] Targeting EGFR Exon 20 Insertions in Non-Small Cell Lung Cancer: Recent Advances and Clinical Updates
    Meador, Catherine B.
    Sequist, Lecia, V
    Piotrowska, Zofia
    CANCER DISCOVERY, 2021, 11 (09) : 2145 - 2157
  • [38] DIFFERENTIAL EFFICACY OF EGFR-TKI ACCORDING TO VARIANTS OF EXON 19 DELETIONAL MUTATION IN NON-SMALL CELL LUNG CANCER
    Kaneda, Toshihiko
    Hata, Akito
    Tanaka, Kosuke
    Kaji, Reiko
    Fujita, Shiro
    Tomioka, Hiromi
    Tomii, Keisuke
    Katakami, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S570 - S570
  • [39] EGFR Amplification Mediates Resistance to TAS121, A Third-Generation EGFR-TKI, in EGFR T790M-Positive Non-Small Cell Lung Cancer
    Watanabe, S.
    Goto, Y.
    Motoi, N.
    Kohno, T.
    Sato, J.
    Morita, R.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Ohe, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2252 - S2252
  • [40] Bevacizumab to combat EGFR-TKI resistance in a patient with advanced non-small cell lung cancer harboring an EGFR mutation: A case report
    Wang, Zhiyi
    Zhou, Pu
    Li, Guanghui
    ONCOLOGY LETTERS, 2016, 12 (01) : 356 - 360
12345